A precise and non-toxic treatment that targets lung cancer cells at the nanoscale is able to effectively kill the cells even at a low dose.
Researchers from Washington State University and the Department of Energy’s Pacific Northwest National Laboratory (PNNL) used tiny tubes made from organic molecules called peptoids to deliver cancer-killing drugs in a targeted manner. The research, led by Yuehe Lin, professor in WSU’s School of Mechanical and Materials Engineering, and Chun-Long Chen, a senior research scientist at PNNL and a joint faculty fellow at the University of Washington, was published as the cover story in the prestigious journal Small.
The biologically-inspired nanotubes, which are about a hundred thousand times thinner than a human hair, were rolled up from membrane-like nanosheets. The drug molecules, fluorescent dyes and cancer-targeting molecules were precisely placed within the nanotubes, enabling them to track the efficiency of drug delivery into the cancer cells.
The new technology allows the two drugs – one for chemotherapy and the other for a less-invasive photodynamic therapy treatment – to be delivered directly to the cancer cells. Photodynamic therapy uses a chemical that, when exposed to light, releases reactive oxygen species (ROS) that kill cancer cells. The researchers’ dual-drug approach enabled the use of a lower dose of the cancer drugs than using a single drug, leading to effective killing of cancer cells with low toxicity.
“By precisely engineering these nanotubes with fluorescent dyes and cancer targeting molecules, scientists can clearly locate tumor cells and track how the drug regimen is performing,” said Lin. “We can also track how nanotubes enter and deliver the drugs inside the cancer cell.”
The team tested the nanotubes on lung cancer cells and found that they delivered the chemotherapy drug doxorubicin directly into the fast-dividing cancer cells, resulting in highly efficient cancer killing while using less chemotherapy drugs.
“This is a promising approach for precision targeting with little damage to healthy surrounding cells,” said Lin.
While other nanomaterials, such as carbon nanotubes, have been used to deliver and track cancer-killing drugs, researchers have found that they are toxic to the body. Furthermore, they didn’t do well at precisely recognizing molecules.
“By using these peptoids, we were able to develop highly programmable nanotubes and a biocompatible delivery mechanism,” said Chen. “We also harnessed the high stability of peptoid and its well-controlled packing to develop nanotubes that are highly stable.”
“Due to their unique structure, these nanotubes can be easily assembled for use in cancer therapy and stay in the body longer for treatment,” said Lin.
The team is now looking for collaboration and funding opportunities with pharmaceutical companies to extend the research into animal and clinical studies.
The Latest on: Lung cancer
via Google News
The Latest on: Lung cancer
- AI can better predict drug response to lung cancer therapieson March 22, 2020 at 4:08 am
Researchers have used Artificial Intelligence (AI) to train algorithms and predict tumour sensitivity in three advanced non-small cell lung cancer therapies which can help predict more accurate ...
- When Cancer And Coronavirus Collide: Fear And Resilienceon March 22, 2020 at 4:01 am
Having advanced cancer while being wary of the COVID-19 virus really sucks. I am speaking both as a doctor and as a person with cancer – since 2016, I have lived with stage 4 lung cancer. The threat ...
- University of Hawaii Cancer Center receives $2.8 million to study ethnic disparities in smoking-related lung canceron March 22, 2020 at 2:16 am
University of Hawaii Cancer Center received a $2.8 million grant to study smoking-related lung cancer disparities between ethnic and racial populations. The National Institute on Minority Health and ...
- Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Updateon March 21, 2020 at 5:12 pm
The aim of this work is to provide evidence-based recommendations updating the 2017 ASCO guideline on systemic therapy for patients with stage IV non-small-cell lung cancer (NSCLC) without driver ...
- AI may help predict responses to non-small cell lung cancer systemic therapieson March 20, 2020 at 1:01 am
Using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC), researchers utilized artificial intelligence (AI) to train algorithms to predict ...
- New melanoma treatments reduce deaths from skin canceron March 20, 2020 at 12:49 am
New treatments for melanoma have dramatically reduced deaths from this often fatal skin cancer. Leaders of a new study report that the death rate from aggressive melanoma that spread to other organs ...
- Screening for Lung Cancer — 10 States, 2017on March 19, 2020 at 9:11 pm
Lung cancer is the leading cause of cancer death in the United States; 148,869 lung cancer-associated deaths occurred in 2016.  Mortality might be reduced by identifying lung cancer at an early ...
- BRIEF-Hansoh Pharma's Ameile Receives Marketing Authorization In China For Second-Line Treatment For Patients With Type Of Non-Small Cell Lung Canceron March 19, 2020 at 9:13 am
Hansoh Pharmaceutical Group Co Ltd : * HANSOH PHARMA’S AMEILE (ALMONERTINIB) RECEIVES MARKETING AUTHORIZATION IN CHINA FOR SECOND-LINE TREATMENT FOR PATIENTS WITH EGFR T790M-MUTATION NON-SMALL CELL ...
- Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemnesson March 18, 2020 at 7:49 am
Drug resistance remains a serious issue of clinical importance and is a consequence of cancer stemness. In this study, we showed that the level of Aldolase A (ALDOA) expression is significantly ...
- Minorities less likely to get recommended lung cancer imagingon March 18, 2020 at 12:36 am
Black and Hispanic Americans are less likely than whites to receive recommended lung cancer imaging, a new study claims. PET-CT imaging is recommended because it provides doctors the best possible ...
via Bing News